Unlock stock picks and a broker-level newsfeed that powers Wall Street.

November 2024 UK Penny Stocks To Watch

In This Article:

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, highlighting global economic interdependencies. Amid such market conditions, investors often seek opportunities in areas like penny stocks—smaller or less-established companies that can offer unique value propositions. Despite their vintage name, penny stocks remain relevant due to their potential for growth and financial resilience, making them an intriguing option for those looking to explore beyond the usual investment avenues.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

ME Group International (LSE:MEGP)

£2.155

£811.93M

★★★★★★

Next 15 Group (AIM:NFG)

£4.05

£402.8M

★★★★☆☆

Secure Trust Bank (LSE:STB)

£3.56

£67.89M

★★★★☆☆

Serabi Gold (AIM:SRB)

£0.925

£70.05M

★★★★★★

Supreme (AIM:SUP)

£1.65

£192.41M

★★★★★★

Ultimate Products (LSE:ULTP)

£1.255

£107.11M

★★★★★★

Luceco (LSE:LUCE)

£1.27

£195.87M

★★★★★☆

Stelrad Group (LSE:SRAD)

£1.41

£179.57M

★★★★★☆

Impax Asset Management Group (AIM:IPX)

£3.325

£425.48M

★★★★★★

Tristel (AIM:TSTL)

£4.40

£209.85M

★★★★★★

Click here to see the full list of 464 stocks from our UK Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Integrated Diagnostics Holdings

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Integrated Diagnostics Holdings plc is a consumer healthcare company offering a range of medical diagnostics services, with a market cap of $229.91 million.

Operations: The company's revenue is primarily derived from its operations in Egypt (EGP 3.97 billion), followed by Jordan (EGP 699.61 million) and Nigeria (EGP 77.09 million).

Market Cap: $229.91M

Integrated Diagnostics Holdings plc, with a market cap of $229.91 million, has shown strong financial performance with significant earnings growth of 138.6% over the past year and high-quality earnings. The company’s debt is well-covered by operating cash flow, and its short-term assets exceed both short- and long-term liabilities. Despite a volatile share price recently, the stock trades at a good value compared to peers. Recent strategic moves include delisting from the Egyptian Exchange while maintaining its listing on the London Stock Exchange, alongside executing a share buyback program to enhance shareholder value.